Upstream Bio, Inc. (UPB) Revenue History
Upstream Bio, Inc. (UPB) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2023-12-31 | $2.38M |
| 2024-12-31 | $2.37M |
| 2025-12-31 | $2.85M |
How UPB compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ACHV | Achieve Life Sciences Inc. | $5.06M |
| XBIT | XBiotech Inc. | $4.01M |
| DYAI | Dyadic International Inc. | $3.09M |
| TXMD | TherapeuticsMD Inc. | $3.02M |
| VTGN | Vistagen Therapeutics Inc. | $1.27M |
These are five companies in the same sector as UPB with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Upstream Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("UPB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | UPB | $6.97 | +1.75% | 0.43M |
| 3 | ||||
| 4 | ||||
| 5 |